Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering. Access is restricted to a trusted-access programme for vetted enterprise customers including Amgen, Moderna, and Thermo Fisher Scientific. OpenAI has launched GPT-Rosalind, a frontier reasoning model built specifically for life […]
The European Investment Bank is lending €20 million to BioLamina, the Swedish biotech that supplies the laminin-based cell culture matrices used by stem cell therapy developers worldwide. The funding will support expanded production of laminin technologies and animal-free drug safety testing methods. BioLamina, the Stockholm-based biotechnology company that produces the protein scaffolding used to grow […]
The Japan-headquartered EV battery manufacturer, controlled by China’s Envision Group and backed by Singapore’s sovereign wealth fund GIC, is mulling an IPO in Hong Kong that could raise up to $2 billion, Bloomberg reported on Thursday. The move marks a significant change from earlier plans to list in the US. Envision AESC, the electric vehicle […]
The Silicon Valley institution has closed roughly $7 billion for its expansion strategy fund, nearly doubling its comparable 2022 vehicle. Alfred Lin and Pat Grady, who took over as co-stewards in November 2025, are making the raise their opening statement on the AI era. Sequoia Capital has raised approximately $7 billion for a new fund, […]
In short: Anthropic has released Claude Opus 4.7, its most capable generally available model, with benchmark-leading scores on SWE-bench Pro (64.3% vs GPT-5.4’s 57.7%), multi-agent coordination for hours-long workflows, 3x higher image resolution, and a 14% improvement in multi-step agentic reasoning with a third of the tool errors. Priced at $5/$25 per million tokens, it […]
Slash, the vertical banking platform built by two college dropouts, has raised a $100M Series C backed by Khosla Ventures and Ribbit Capital. The company’s valuation has nearly quadrupled since its May 2025 Series B, the latest leg of a comeback story that began when its core market evaporated overnight. Slash, the San Francisco-based vertical […]
STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by existing investors including Pfizer Ventures and M Ventures. STORM Therapeutics, a Cambridge-based clinical-stage biotech targeting RNA modifications to treat cancer, has raised $56 million in […]
The Copenhagen fintech has built a platform of specialised AI agents that handle KYC and KYB work, document reviews, ownership mapping, risk rationale, in minutes rather than hours. NEA led the Series A; Northzone, Seedcamp, and PSV Tech participated. Spektr, a Copenhagen-based startup building AI infrastructure for financial compliance, has raised $20 million in a […]
The European Commission today sent Google its preliminary findings under the Digital Markets Act, proposing six specific measures governing how Google must share search ranking, query, click, and view data with competing search engines. AI chatbots with search functionalities are explicitly included as potential data beneficiaries. A public consultation opens tomorrow. The European Commission has […]
